Scientists have known for decades that caloric restriction leads to a longer lifespan. It has also been observed that chronic inflammation increases with age. But any relationship between the two had remained unexplored.
But in a new study, published in Cell Metabolism, Harvard Medical School researchers at Joslin Diabetes Center have uncovered a new mechanism of lifespan extension that links caloric restriction with immune-system regulation.
“Modulating immune activity is an important aspect of dietary restriction,” said senior author on the paper Keith Blackwell, professor of genetics in the Blavatnik Institute at Harvard Medical School and associate director of research and senior investigator at Joslin. “And it is important for longevity regulation and, in this context, increasing lifespan.”
In the study, Blackwell and his team found that caloric restriction reduces levels of innate immunity by decreasing the activity of a regulatory protein called p38, triggering a chain reaction effect ending in a reduced immune response.
Innate immunity is like the security guard of the body, keeping an eye out for any unwelcome bacteria or viruses. If the innate immune system spots something, it activates an acute immune response.
People need some degree of both kinds of immunity to stay healthy, but an overactive innate immune system—which occurs more often as we age—means constant low-grade inflammation, which can lead to myriad health issues.
“[Before this study,] people looked at what happens to immunity and aging in humans, but no one had ever looked in any organism at whether modulating immunity or its activities is involved in lifespan extension or can be beneficial as part of an anti-aging program,” said Blackwell.
The research was conducted in the microscopic nematode worm C. elegans. The most fundamental genes and regulatory mechanisms found in these worms are typically simpler versions of those present in humans, making them a good model for studying human aging, genetics and disease.
Blackwell and his team analyzed the levels of proteins and actions of genetic pathways during periods of caloric restriction. They were able to zero in on a particular genetic pathway that was regulated by the p38 protein.
They saw that when p38 was totally inactive, caloric restriction failed and had no impact on innate immunity. When it was active, but at lower levels than normal, it triggered the genetic pathways that turned down the innate immune response to an optimal level.
“That was the most surprising thing we found. The pathway was down regulated even though it was critical,” said Blackwell.
That this immune-regulating response was activated by nutrients, rather than bacteria, was also surprising. This adds to a growing body of evidence tying metabolism to the immune system.
“This is really an emerging field in mammals now, so called immunometabolism—the idea that there are ancient links between metabolism and immunity,” said Blackwell.
“We were able to show in this really very primitive immune system that it is regulated metabolically and affects lifespan and health independently of an anti-pathogen function. That is when I started calling this a primitive immunometabolic pathway or an immunometabolic regulation,” Blackwell said.
After making this discovery, Blackwell was curious to know if the well-known longevity mechanism of reduced IGF1 signaling also acted on the immune system.
For more than 20 years, study after study in many different organisms has confirmed that lower levels of IGF1 signaling contributes to a longer lifespan. This is thought to be due to the activation of protective factors by a protein called FOXO (called DAF-16 in C. elegans).
In the new study, Blackwell and his team discovered that when IGF signaling was reduced in the worms, the chain reaction set off by the FOXO-like DAF-16 not only boosted protective mechanisms but also led to a reduction of the worms’ appetites. This naturally put the subjects in a state of caloric restriction.
“This links the growth mechanism [of IGF1 signaling] to food consumption and food seeking behavior in a big way,” said Blackwell.
A reduction in the activity of the FOXO-like gene seems to tell the worms that they are in a fasting-like state and that nutrients may be scarce. This directs the worms to conserve energy, leading to a reduction in food intake.
This self-imposed caloric restriction then leads to the lowering of the innate immune response. Blackwell plans to further study how the FOXO protein acts to suppress appetite and to understand whether that might eventually lead to drug development.
The genes responsible for the phenomena observed in this study are conserved in humans. This opens up the possibility of human medical applications, from optimizing the immune system to drug development for appetite control.
“The ultimate goal is to be able to manipulate healthy lifespan in a person,” said Blackwell.
“Not to make people live to 120, 130, but to extend the period of healthy life. And chronic inflammation is a major factor in human aging. The hope is that some of the specific mechanisms could translate to optimizing immune function in humans during aging to enhance health in human lifespan,” Blackwell said.
The study was supported by grants from the National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases.
Adapted from a Joslin news release.